TY  - JOUR 
AU  - Roy Luzarraga, Marina
AU  - Reynolds, Louise E.
AU  - Luxán-Delgado, Beatriz de
AU  - Maiques, Oscar
AU  - Wisniewski, Laura
AU  - Newport, Emma L
AU  - Rajeeve, Vinothini
AU  - Drake, Rebecca J. G.
AU  - Gómez Escudero, Jesús
AU  - Richards, Frances M.
AU  - Weller, Céline
AU  - Dormann, Christof
AU  - Meng, Ya-Ming
AU  - Vermeulen, Peter B.
AU  - Saur, Dieter
AU  - Sanz-Moreno, Victoria
AU  - Wong, Ping Pui
AU  - Géraud, Cyrill
AU  - Cutillas, Pedro R.
AU  - Hodivala-Dilke, Kairbaan M.
PY  - 2022
SN  - 0008-5472
UR  - http://hdl.handle.net/10366/169245
AB  - [EN]Despite substantial advances in the treatment of solid cancers, resistance to therapy remains a major obstacle to prolonged progression-free survival. Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, with a high level...
LA  - eng
PB  - American Association for Cancer Research
KW  - Cancer
KW  - FAK
KW  - Metastasis
KW  - Pancreas
TI  - Suppression of endothelial cell FAK expression reduces pancreatic ductal adenocarcinoma metastasis after gemcitabine treatment
DO  - https://doi.org/10.1158/0008-5472.CAN-20-3807
T2  - Cancer Research
VL  - 82
ER  -